Leukemia Patient’s Urgent Search for a Stem Cell Match: How You Can Help Save a Life
Eddie Kaufman, a college sophomore from Roanoke University and native of Lackawanna County, is currently facing one of the biggest battles of his life—leukemia. Diagnosed last summer, Eddie’s condition requires a life-saving stem cell transplant, and his family is now calling on the community to step up and potentially save his life. Understanding Leukemia and […]
Intestinal Cell Regeneration Trigger Identified
Researchers at the University of Colorado Anschutz Medical Campus have identified a crucial biochemical process called H3K36 methylation that acts as a “switch” for intestinal cell regeneration after injury. This process controls whether normal intestinal cells can revert to a regenerative stem cell state. The discovery, published in Nature Cell Biology, reveals that H3K36 methylation must be removed for cells to dedifferentiate and […]
Celularity and BlueSphere Bio Collaborate on Cell Therapy Manufacturing
Celularity Inc., a cellular medicine company, has entered into a collaboration agreement with BlueSphere Bio (BSB).? Celularity will leverage its manufacturing capabilities to produce BSB’s T cell receptor (TCR) T cell therapies.? This partnership will focus on manufacturing and quality control at Celularity’s New Jersey facility for BSB’s therapies, including a treatment for Acute Myelogenous […]
Genetically Engineered Stem Cells Fight Gastroesophageal Cancer
Dr. Saar Gill of the University of Pennsylvania received a $450,000 grant from the DeGregorio Family Foundation to continue research on genetically engineered stem cells to combat gastroesophageal cancer. This builds upon previous work using Chimeric Antigen Receptor (CAR) macrophages to target and destroy cancer cells within solid tumors. The ultimate goal is to develop a long-lasting supply of cancer-fighting cells. […]
CellFE Launches T-REST Kit: Revolutionizing CAR-T Cell Therapy Manufacturing for Breakthrough Cancer Treatments
CellFE, a pioneering biotechnology company, has unveiled its groundbreaking T-REST Resting T Cell Kit, a first-in-class solution designed to revolutionize CAR-T cell therapy manufacturing. This innovative kit aims to enhance the quality and efficacy of CAR-T therapies by optimizing the resting state of T cells, a critical factor in improving patient outcomes. By addressing key […]
Newton Rallies to Save Teen with Leukemia: Join the Stem Cell Donor Drive
In the small town of Newton, Kansas, the community is rallying together for a noble cause—a stem cell donor drive to help save the life of Jonah Huet, a 15-year-old high school student recently diagnosed with leukemia. Jonah, an avid volleyball player and passionate marching band member, urgently needs a stem cell transplant, but no […]
Eterna Therapeutics Investigates ERNA-101 in Cancer Models
Eterna Therapeutics, a preclinical-stage company, announced a research collaboration with MD Anderson Cancer Center to evaluate its lead induced mesenchymal stem cell therapy, ERNA-101, for treating ovarian and breast cancers. ERNA-101, a proprietary allogenic cell therapy, aims to stimulate antitumor immunity. The research will assess ERNA-101’s effects both in vitro and in vivo, with potential future studies exploring […]
Revolutionizing Cancer Treatment: The Impact of Stem Cell Transplants at Community Health Network MD Anderson Cancer Center
At Community Health Network’s MD Anderson Cancer Center, a groundbreaking milestone has been reached with the center’s first stem cell transplant. This significant medical advancement involves the infusion of a patient’s own stem cells, which were harvested, frozen, and reintroduced after a high dose of chemotherapy. The procedure aims to restore the bone marrow and […]
Factor Bioscience and Eterna Therapeutics Partner to Accelerate Advanced Cell Therapies for Cancer, Rare Diseases, and Autoimmune Disorders
In a groundbreaking collaboration that promises to reshape the future of medicine, Factor Bioscience and Eterna Therapeutics have announced an exclusive license agreement to accelerate the development of stem cell-based therapies for oncology, autoimmune disorders, and rare diseases. The agreement is centered around the utilization of Factor’s proprietary induced pluripotent stem cell (iPSC) technologies, which […]
Unlocking the Future of Stem Cell Transplants: New Advances in Hematopoietic Cell Therapies
In the video below, Dr. Michael Grunwald discusses the transformative potential of hematopoietic cell transplantation, also known as stem cell or bone marrow transplantation, particularly for patients with myeloproliferative neoplasms (MPNs). This advanced treatment, though not necessary for all MPN patients, offers a beacon of hope for a select group, leveraging the body’s immune system […]